Stock Analysis | Synopsys Outlook - A Closer Look at the Technical Downturn and Market Reactions

Generated by AI AgentAinvest Stock Digest
Tuesday, Aug 19, 2025 11:55 am ET2min read
Aime RobotAime Summary

- Synopsys faces a bearish technical outlook with weak indicators and U.S. export curbs halting China sales.

- Competitors like Rivian-Volkswagen and Quest Software boost tech investments, signaling industry shifts toward software and AI.

- Analysts show mixed ratings (2.72 vs. 4.50 average), while institutional inflows remain slightly positive amid retail outflows.

- Bearish technical signals (MACD death cross, engulfing pattern) dominate, with stock down 0.50% and a 2.68 internal diagnostic score.

Market Snapshot

Takeaway:

is facing a weak technical outlook, with bearish indicators dominating the chart and recent price momentum drifting lower. An internal diagnostic score of 2.68 underscores the bearish tilt.

News Highlights

1. US Export Curbs Impact Synopsys: The Trump administration has introduced new export restrictions on chip design software, directly affecting companies like Synopsys. The firm has reportedly halted new sales and services in China, a critical market for the company.

2. Strategic Software Investment:

and Volkswagen Group are forming a joint venture to develop next-generation software-defined vehicle (SDV) platforms. While this doesn't directly involve Synopsys, it highlights the growing strategic importance of software in the automotive and tech sectors—areas where Synopsys is also active.

3. Capital Infusion in Tech Rivals: Quest Software recently closed a $350 million capital infusion to boost AI innovation, signaling broader industry moves toward tech-driven growth. While Synopsys is not mentioned in this news, the move highlights increased investment in technology infrastructure.

Analyst Views & Fundamentals

Analyst Consensus: The simple average analyst rating is 4.50, while the performance-weighted rating is lower at 2.72. This divergence suggests that while some analysts are optimistic, the historical performance of those making the calls is mixed. Rating consistency is low, with one analyst giving a "Strong Buy" and another a "Buy."

Price Trend: The stock has fallen by 0.50% in recent trading, aligning with the bearish expectations of the market. The mismatch between high-level ratings and the downward price movement suggests caution for investors.

Fundamental Highlights

  • ROE (diluted) (YoY growth rate %): 5.04% (Internal diagnostic score: 7.43)
  • ROA: 1.45% (Internal diagnostic score: 7.43)
  • Profit-MV: -1.52 (Internal diagnostic score: 1.00)
  • Cash-UP: 22.10% (Internal diagnostic score: 7.43)
  • Net profit / Total profit (%): 93.48% (Internal diagnostic score: 1.00)

Money-Flow Trends

Big money is showing mixed signals. The overall inflow ratio is 47.33%, with large and extra-large investors showing slightly positive trends (Large inflow ratio: 50.47%, Extra-large inflow ratio: 45.82%). Retail flows are also negative, with small and medium investors showing outflows (Small inflow ratio: 49.76%, Medium inflow ratio: 49.89%). An internal diagnostic fund flow score of 7.75 (score level: good) suggests that institutional money is still showing some confidence despite the weak technical backdrop.

Key Technical Signals

Recent technical signals are weak, with bearish indicators clearly dominating the chart:

  • WR Overbought: Internal diagnostic score of 2.43. This indicator suggests a neutral-to-bearish outlook, with historical signals showing a 47% win rate and a -0.26% average return.
  • MACD Death Cross: Internal diagnostic score of 1.00. A bearish signal with a very low win rate of 22.22% and an average return of 0.26%.
  • Bullish Engulfing: Internal diagnostic score of 1.00. This pattern is currently biased bearish, with a 33.33% win rate and -0.66% average return.

Recent Chart Activity

  • 2025-08-06: MACD Death Cross occurred
  • 2025-08-12: Bullish Engulfing pattern appeared
  • 2025-08-11: WR Oversold signal was detected
  • 2025-07-29 & 07-30: WR Overbought signals were seen

Summary Insight: The technical momentum is clearly negative, with bearish signals outpacing bullish ones (3 bearish vs. 0 bullish). The market appears to be in a consolidation phase with a high risk of further decline.

Conclusion

Given the weak technical outlook and the bearish indicators currently in play, investors should consider avoiding Synopsys for now. While the fundamentals still look reasonably strong and big money remains slightly positive, the recent technical signals and price action suggest a cautious approach. A pullback could be on the horizon, and it may be wise to wait for clearer momentum before entering new positions.

Comments



Add a public comment...
No comments

No comments yet